CEO SUMMARY: Is the New Year’s spate of deals involving the sales of hospital lab outreach programs and a new joint venture the first tremors of an impending earthquake of similar transactions? In the first 10 weeks of 2017, Laboratory Corporation of America, Quest Diagnostics, and Sonic Healthcare announced significant agreements to purchase sizeable hospital
Tag: laboratory acquisitions
LIFELABS QUEBEC TO BE ACQUIRED BY GAMMA-DYNACARE
LAST WEEK, IT WAS ANNOUNCED that Gamma-Dynacare Medical Laboratories had signed a definitive agreement with LifeLabs Limited Partnership to purchase LifeLabs Quebec. Both parties expect the transaction to close by April 28, 2012.
This laboratory acquisition is notable for at least three reasons. First, it involves Canada’s two primary national laboratory
CEO SUMMARY: Given the specific news stories that make up THE DARK REPORT’S list of the “Top Ten Lab Stories for 2011,” it might be said that 2011 was a rather quiet year overshadowed by anticipation of the coming reforms mandated by the Accountable Care Act of 2010. For the clinical lab testing industry, 2011
CEO SUMMARY: More buyers are crowding into the lab testing industry and looking to acquire anatomic pathology testing companies. These buyers are willing to pay strong prices to acquire AP labs and companies which they determine to be a strategic fit. All of this acquisition activity is happening even as the Baby Boomer generation of
CEO SUMMARY: With the announcement that it will purchase CBL Path, Inc., Sonic Healthcare, Ltd., becomes the latest public laboratory company to buy a sizeable presence in the national anatomic pathology (AP) marketplace. For CBL Path, founded in 2003 by ex-Dianon executives and sales professionals, it is the exit strategy for which they have long
CEO SUMMARY: Subject to court approval, Laboratory Corporation of America is poised to acquire the assets of California-based Westcliff Medical Laboratories, Inc., which just filed a Chapter 11 bankruptcy action in federal court on May 19. In a separate transaction, LabCorp has an agreement to acquire Diamond Reference Laboratory of Diamond Bar, California. The two
IN RECENT WEEKS, the last of the nation’s largest public laboratory companies released year-end 2009 financial reports. Each lab firm’s financial report provides useful insights about active trends in the lab testing marketplace, particularly in lab testing referred by office-based physicians.
Quest Diagnostics Incorporated and Laboratory Corporation of America are the two dominant national companies competing
CEO SUMMARY: Along with a recovering economy, the possibility of an increase in the capital gains tax rate for 2011 may encourage owners of clinical labs and anatomic pathology companies to sell their businesses during 2010. That could make 2010 a busy year for laboratory mergers and acquisitions, particularly if valuations for laboratory companies hold
CEO SUMMARY: After two years of relatively slow sales of clinical labs, there is pent up demand for lab acquisitions and a declining supply of independent labs available for sale. That’s the assessment of one expert on laboratory mergers and acquisitions, who predicts that the accelerating pace of clinical lab and anatomic pathology practice acquisitions
THERE’S A NEW TRANSITION JUST GETTING STARTED in the laboratory testing industry. For the past two decades, laboratory acquisition activity has primarly centered around independent clinical laboratories—often owned by local pathologists. This was true in both the size of the transactions and in the volume of transactions. Our stories on pages 3-9 describe these processes.